Top 100 2025
Company
HEKETISS SA
Incorporated
November 2021
Headquarter
Plan-les-Ouates
Support
Biotech Biotech Organ and Tissues

Off-the-shelf stem cell therapy for wound and skin repair

Turning fat into life.

HekeTiss is a pioneering cell therapy biotech focused on developing patent-backed, off-the-shelf allogeneic stem cell therapies to accelerate the regeneration of damaged skin and restore skin health. Founded in 2021 as a spin-off from UNIGE and HUG, HekeTiss developed TrophiPatch, a first-of-its-kind skin patch derived from functionally enhanced donor fat stem cells. TrophiPatch is designed to regenerate blood vessels in chronic wounds, an essential factor for superior healing. Convenient and easy to apply, the patch naturally resorbs, providing a unique and effective solution for wounds that resist conventional treatments.

Company News

Find here the latest news about the company.

Company Awards